Mesenchymal stem/stromal cells (MSCs) have been carefully examined to have tremendous
potential in regenerative medicine. With their immunomodulatory and regenerative …

Systemic lupus erythematosus (SLE) is a chronic multisystem auto-immune disease with
extremely varied clinical manifestations and a complex pathogenesis. New insights in SLE …

The prevention of chronic damage, especially in early disease phases, remains an unmet
need in the management of Systemic Lupus Erythematous (SLE) patients, despite the …

Systemic Lupus Erythematosus (SLE) is a systemic autoimmune disease and is extremely
heterogeneous in terms of immunological features and clinical manifestations. This …

Objective We carried out a systematic review (SR) of adherence in diagnostic and
prognostic applications of ML in SLE using the Transparent Reporting of a multivariable …

Background: Several cardiovascular (CV) risk algorithms are available to predict CV events
in the general population. However, their performance in patients with rheumatoid arthritis …

Objective: The purpose of this study was to determine the distribution of organ damage in a
cohort of systemic lupus erythematosus (SLE) patients and to evaluate the roles of clinical …

Objective Osteoporosis (OP) and fragility fractures (FF) are common comorbidities in
patients with systemic lupus erythematosus (SLE). This study aimed to (1) assess the …

Artificial intelligence and machine learning applications are emerging as transformative
technologies in medicine. With greater access to a diverse range of big datasets …

1 DRUGS, AUTOANTIBODIES AND GENES CONTRIBUTE TO THE DEVELOPMENT OF
CHRONIC DAMAGE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS Page 1 1 …